Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 31 Mar 2022 for Soleno Therapeutics INC. Read the official filing
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-14.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Abingworth LLP: trading record in brief
Abingworth LLP discloses dealings in 3 companies, chiefly Sierra Oncology, Inc., Soleno Therapeutics Inc and Vera Therapeutics, Inc. Over a trading history stretching from 18 May 2021 to 29 March 2022, the count stands at 3 filings.
On the market, this insider has only ever bought: 1 purchase. The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant. Since January 2022: 1 purchase and no sales on the market.
Most recently, on 31 March 2022, the filings show an open-market purchase in Soleno Therapeutics Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Abingworth LLP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
7,720,000 sharesCommon StockSEC:0000905718-22-000523:0
Canonical exit: 27 Jun 2022 (T+90)
287,471 shares@ US$13.20100.0% of flowCommon Stock, $0.001 par valueSEC:0000905718-22-000177:0
2,187,504 sharesClass A Common StockSEC:0000905718-21-000712:0
3 of 3 declarations
